Ergoteles’s Encompass Health EHC Stock Holding History

Ergoteles’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-67,216	Closed	-$3M	–	1656
2022 Q2	$3M	Buy	+67,216	New	+$3.45M	0.09%	229
2021 Q1	–	Sell	-3,576	Closed	-$235K	–	866
2020 Q4	$235K	Buy	+3,576	New	+$210K	0.01%	574

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Ergoteles's EHC Position: Q3 2022 in Review

Ergoteles sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 67,216 shares — an estimated $3M sold.

Ergoteles first reported a position in EHC in Q4 2020 and held it in 2 quarters. The position peaked at $3M in Q2 2022. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

Ergoteles reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 67,216 Encompass Health shares in Q3 2022, an estimated $3M.
Ergoteles first reported a position in Encompass Health in Q4 2020 and held it in 2 quarters.
Ergoteles's Encompass Health position peaked at $3M in Q2 2022.
346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.